MGP and colorectal carcinoma: Caiado H et al. [49] reported, in 2018, the first study showing that increased levels of mRNA expression of MGP are associated with a worse prognosis of CRC, with the occurrence of metastases [3] associated with a lower chance of survival [49]; these results were confirmed in the following years by others [53].